News | May 25, 2022
Piramal Pharma Solutions upgrades Pithampur site
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Subscribe To Our Newsletter & Stay Updated
